These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6713348)

  • 41. Node-negative breast cancer treated by modified radical mastectomy without adjuvant therapies: variables associated with disease recurrence and survivorship.
    Huseby RA; Ownby HE; Frederick J; Brooks S; Russo J; Brennan MJ
    J Clin Oncol; 1988 Jan; 6(1):83-8. PubMed ID: 3335894
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictive value of some clinical and pathological parameters on upper level axillary lymph node involvement in breast cancer.
    Toma S; Leonessa F; Romanini A; Badellino F; Bonassi S; Nicolo G; Rosso R
    Anticancer Res; 1991; 11(4):1439-43. PubMed ID: 1746901
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The reversal of recurrence hazard rate between ER positive and negative breast cancer patients with axillary lymph node dissection (pathological stage I-III) 3 years after surgery.
    Kiba T; Inamoto T; Nishimura T; Ueno M; Yanagihara K; Teramukai S; Kato H; Toi M; Fukushima M
    BMC Cancer; 2008 Nov; 8():323. PubMed ID: 18990247
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93.
    ; Rudenstam CM; Zahrieh D; Forbes JF; Crivellari D; Holmberg SB; Rey P; Dent D; Campbell I; Bernhard J; Price KN; Castiglione-Gertsch M; Goldhirsch A; Gelber RD; Coates AS
    J Clin Oncol; 2006 Jan; 24(3):337-44. PubMed ID: 16344321
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Soluble and nuclear oestrogen receptor status in human breast cancer in relation to prognosis.
    Leake RE; Laing L; McArdle C; Smith DC
    Br J Cancer; 1981 Jan; 43(1):67-71. PubMed ID: 7459240
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinicopathological characteristics and prognostic factors of breast cancer with estrogen- and progesterone-receptor negative and HER-2 overexpression].
    Fan Y; Guan Y; Zhao WH; Li Q; Xu BH
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):917-20. PubMed ID: 19173993
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alterations in hormonal receptor expression and HER2 status between primary breast tumors and paired nodal metastases: discordance rates and prognosis.
    Ba JL; Liu CG; Jin F
    Asian Pac J Cancer Prev; 2014; 15(21):9233-9. PubMed ID: 25422206
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characteristics and outcomes of sentinel node-positive breast cancer patients after total mastectomy without axillary-specific treatment.
    Milgrom S; Cody H; Tan L; Morrow M; Pesce C; Setton J; Rogers K; Arnold B; Eaton A; Catalano J; McCormick B; Powell S; Ho A
    Ann Surg Oncol; 2012 Nov; 19(12):3762-70. PubMed ID: 22576064
    [TBL] [Abstract][Full Text] [Related]  

  • 49. T1a and T1b breast cancer: a twelve-year experience.
    Visser TJ; Haan M; Keidan R; Lucas R; Ingold J; Glover J; Riggo P
    Am Surg; 1997 Jul; 63(7):621-6. PubMed ID: 9202537
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of the pathologic and prognostic correlates of estrogen receptors in primary breast cancer.
    Skinner JR; Wanebo HJ; Betsill WL; Wilhelm MC; Drake CR; Macleod RM
    Ann Surg; 1982 Dec; 196(6):636-41. PubMed ID: 7149814
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes.
    Rouzier R; Extra JM; Klijanienko J; Falcou MC; Asselain B; Vincent-Salomon A; Vielh P; Bourstyn E
    J Clin Oncol; 2002 Mar; 20(5):1304-10. PubMed ID: 11870173
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Female breast cancer with 'clandestine' lymph node metastases.
    van Bogaert LJ
    East Afr Med J; 1998 Nov; 75(11):644-6. PubMed ID: 10065176
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognosis for breast cancer surgery and radiation therapy compared with mastectomy alone. A retrospective analysis of 759 patients with stage I/II breast cancer.
    Janjan NA; Murray KJ; Conway P; Walker A; Wilson JF
    Cancer; 1992 Jun; 69(11):2842-8. PubMed ID: 1571915
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study.
    Mansour EG; Gray R; Shatila AH; Osborne CK; Tormey DC; Gilchrist KW; Cooper MR; Falkson G
    N Engl J Med; 1989 Feb; 320(8):485-90. PubMed ID: 2915651
    [TBL] [Abstract][Full Text] [Related]  

  • 55. THE SIGNIFICANCE OF REGIONAL LUMPH NODE METASTASES IN BREAST CARCINOMA.
    DEVITT JE
    Can Med Assoc J; 1965 Aug; 93(7):289-93. PubMed ID: 14319790
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Negative margin status improves local control in conservatively managed breast cancer patients.
    Obedian E; Haffty BG
    Cancer J Sci Am; 2000; 6(1):28-33. PubMed ID: 10696736
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The prognostic value and relationships of patient characteristics, estrogen and progestin receptors, and site of relapse in primary breast cancer.
    Alexieva-Figusch J; Van Putten WL; Blankenstein MA; Blonk-Van Der Wijst J; Klijn JG
    Cancer; 1988 Feb; 61(4):758-68. PubMed ID: 3338038
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The prognostic value of estrogen receptor determinations in patients with primary breast cancer: an update.
    Furmanski P; Saunders DE; Brooks SC; Rich MA
    Cancer; 1980 Dec; 46(12 Suppl):2794-6. PubMed ID: 7448723
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Does a Positive Axillary Lymph Node Needle Biopsy Result Predict the Need for an Axillary Lymph Node Dissection in Clinically Node-Negative Breast Cancer Patients in the ACOSOG Z0011 Era?
    Pilewskie M; Mautner SK; Stempel M; Eaton A; Morrow M
    Ann Surg Oncol; 2016 Apr; 23(4):1123-8. PubMed ID: 26553439
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
    Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB
    J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.